News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,542 Results
Type
Article (88044)
Company Profile (447)
Press Release (794028)
Multimedia
Podcasts (258)
Webinars (39)
Section
Business (265379)
Career Advice (4110)
Deals (39821)
Drug Delivery (194)
Drug Development (91660)
Employer Resources (208)
FDA (18619)
Job Trends (17433)
News (396758)
Policy (39829)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3076)
Academic (2)
Accelerated approval (65)
ADA (50)
Adcomms (44)
Allergies (218)
Alliances (56655)
ALS (253)
Alzheimer's disease (2068)
Antibody-drug conjugate (ADC) (627)
Approvals (19059)
Artificial intelligence (920)
ASCO (344)
Autoimmune disease (406)
Automation (71)
Bankruptcy (404)
Best Places to Work (12624)
BIO (81)
Biologics (3)
BIOSECURE Act (23)
Biosimilars (275)
BioSpace Insights (243)
Biotechnology (250)
Bladder cancer (226)
Brain cancer (87)
Breast cancer (887)
Cancer (7055)
Cardiovascular disease (602)
Career advice (3558)
Career pathing (58)
CAR-T (409)
CDC (77)
Celiac Disease (3)
Cell therapy (1118)
Cervical cancer (60)
Clinical research (79538)
Collaboration (2585)
Commercialization (9)
Company closure (9)
Compensation (1710)
Complete response letters (122)
COVID-19 (3050)
CRISPR (133)
C-suite (1465)
Cystic fibrosis (173)
Data (9380)
Decentralized trials (3)
Denatured (100)
Depression (211)
Dermatology (120)
Diabetes (744)
Diagnostics (7737)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (465)
Drug pricing (247)
Drug shortages (39)
Duchenne muscular dystrophy (356)
Earnings (102673)
Editorial (82)
Employer branding (25)
Employer resources (178)
Events (139095)
Executive appointments (1289)
FDA (23111)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (25)
Frontotemporal dementia (38)
Funding (2109)
Gene editing (289)
Generative AI (87)
Gene therapy (885)
GLP-1 (1325)
Government (5584)
Grass and pollen (8)
Guidances (434)
Healthcare (21290)
Hematology (198)
HIV (108)
Huntington's disease (74)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (129)
Immunology and inflammation (382)
Immuno-oncology (126)
Indications (241)
Infectious disease (3470)
Inflammatory bowel disease (249)
Inflation Reduction Act (17)
Influenza (155)
Intellectual property (353)
Interviews (814)
IPO (17981)
IRA (61)
Job creations (5126)
Job search strategy (2833)
JPM (73)
Kidney cancer (27)
Labor market (131)
Layoffs (707)
Leadership (58)
Legal (10118)
Licensing (13)
Liver cancer (112)
Longevity (40)
Lung cancer (946)
Lymphoma (510)
Machine learning (69)
Management (69)
Manufacturing (1374)
Marketing (14)
MASH (235)
Medical affairs (1)
Medical device (15348)
Medtech (15592)
Mergers & acquisitions (23269)
Metabolic disorders (1928)
mRNA (290)
Multiple sclerosis (218)
NASH (24)
Neurodegenerative disease (563)
Neuropsychiatric disorders (141)
Neuroscience (3979)
Neurotech (1)
NextGen: Class of 2026 (7632)
Non-profit (5154)
Now hiring (89)
Obesity (915)
Opinion (389)
Ovarian cancer (259)
Pain (308)
Pancreatic cancer (388)
Parkinson's disease (445)
Partnered (41)
Patents (726)
Patient recruitment (906)
Peanut (73)
People (68250)
Pharmaceutical (68)
Pharmacy benefit managers (38)
Phase 1 (24584)
Phase 2 (34557)
Phase 3 (26009)
Pipeline (11658)
Policy (412)
Postmarket research (3511)
Preclinical (11003)
Press Release (72)
Prostate cancer (372)
Psychedelics (86)
Radiopharmaceuticals (397)
Rare diseases (1422)
Real estate (7402)
Recruiting (83)
Regulatory (30912)
Reports (85)
Research institute (2784)
Resumes & cover letters (646)
Rett syndrome (50)
RNA editing (32)
RSV (102)
Schizophrenia (206)
Series A (363)
Series B (266)
Service/supplier (12)
Sickle cell disease (137)
Special edition (34)
Spinal muscular atrophy (194)
Sponsored (56)
Startups (4331)
State (2)
Stomach cancer (21)
Supply chain (153)
Tariffs (105)
The Weekly (155)
Vaccines (1359)
Venture capital (152)
Weight loss (621)
Women's health (158)
Worklife (26)
Date
Today (17)
Last 7 days (424)
Last 30 days (2481)
Last 365 days (32915)
2026 (21526)
2025 (32529)
2024 (37515)
2023 (42563)
2022 (53927)
2021 (58719)
2020 (57663)
2019 (51334)
2018 (39114)
2017 (37161)
2016 (38235)
2015 (44418)
2014 (39658)
2013 (36208)
2012 (38169)
2011 (38097)
2010 (38600)
Location
Africa (1296)
Alabama (108)
Alaska (7)
Arizona (438)
Arkansas (16)
Asia (52390)
Australia (9194)
California (15394)
Canada (4290)
China (1767)
Colorado (663)
Connecticut (682)
Delaware (473)
Europe (120471)
Florida (2339)
Georgia (502)
Hawaii (5)
Idaho (69)
Illinois (1323)
India (127)
Indiana (703)
Iowa (28)
Japan (662)
Kansas (150)
Kentucky (61)
Louisiana (66)
Maine (95)
Maryland (1851)
Massachusetts (11180)
Michigan (433)
Minnesota (857)
Mississippi (7)
Missouri (178)
Montana (37)
Nebraska (31)
Nevada (166)
New Hampshire (92)
New Jersey (4067)
New Mexico (37)
New York (4050)
North Carolina (2035)
North Dakota (11)
Northern California (7780)
Ohio (481)
Oklahoma (31)
Oregon (48)
Pennsylvania (2986)
Puerto Rico (33)
Rhode Island (55)
South America (1658)
South Carolina (93)
South Dakota (2)
Southern California (6113)
Tennessee (257)
Texas (2524)
United States (54847)
Utah (467)
Vermont (2)
Virginia (389)
Washington D.C. (88)
Washington State (1243)
West Virginia (4)
Wisconsin (175)
Wyoming (4)
882,542 Results for "proceedings of the national academy of sciences pnas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Autoimmunity BioSolutions Co-Founder Dr. Mariano A. Garcia-Blanco Inducted into the National Academy of Sciences
May 19, 2026
·
5 min read
Biotech Bay
First-in-Disease Use of Kyverna Therapeutics’ KYV-101 in Patient With Severe Stiff-Person Syndrome Published in Proceedings of the National Academy of Sciences (PNAS)
Kyverna Therapeutics, Inc. (Kyverna) announced today the publication in Proceedings of the National Academy of Sciences (PNAS)1 of a report describing the first use of KYV-101, a fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, in a 69-year-old patient suffering from treatment-refractory stiff-person syndrome (SPS) as part of a named-patient use in Germany for critically ill individuals who fail conventional therapies.
June 17, 2024
·
6 min read
Press Releases
Kovina Therapeutics Announces Publication in PNAS Validating HPV E6 Targeted Therapeutic Approach
June 19, 2026
·
2 min read
Pharm Country
Tiziana Life Sciences Announces Publication in Proceedings of the National Academy of Sciences (PNAS) Illustrating the Immunological Basis of the Mechanism of Action for Intranasal Foralumab
Tiziana Life Sciences Ltd. today announced a publication in the preeminent1 journal, Proceedings of the National Academy of Sciences (PNAS), that illustrates the immunological basis of the mechanism of action (MoA) for intranasal foralumab.
March 8, 2023
·
4 min read
Press Releases
Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium
June 9, 2026
·
4 min read
Press Releases
Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium
June 11, 2026
·
8 min read
Press Releases
Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
April 22, 2026
·
8 min read
Press Releases
Dr. Marc Hurlbert Begins Tenure as Chief Executive Officer of the National Kidney Foundation
July 1, 2026
·
4 min read
Biotech Bay
GPCR Therapeutics Announces Publication in PNAS Using Cutting Edge Spectroscopy to Detect GPCR Heteromers on Live Cancer Cells
GPCR Therapeutics, Inc., a clinical-stage, international biopharmaceutical company, is pleased to announce the publication in the esteemed scientific journal, Proceedings of the National Academy of Sciences (PNAS) that was spearheaded by Dr. Niña Caculitan, Director of Clinical Development.
April 1, 2024
·
2 min read
BioForest
A New Study in the Proceedings of the National Academy of Sciences (PNAS) Demonstrates the Ability of a Novel Peptide to Selectively Detect and Neutralize an Early Molecular Trigger of Alzheimer’s and Other Neurodegenerative Diseases
AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, today announced that this week the Proceedings of the National Academy of Sciences (PNAS) will publish results of a groundbreaking study demonstrating a customized, synthetic peptide’s ability to selectively detect Alzheimer’s disease.
December 5, 2022
·
4 min read
1 of 88,255
Next
